Screening compound: C21H27N5O3S (L575-0190)

Screening compound: C<sub>21</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub>S (L575-0190)
Screening compound: C<sub>21</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub>S (L575-0190) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C21H27N5O3S (L575-0190)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L575-0190

Molecular Formula

C21H27N5O3S (C21 H27 N5 O3 S)

Compound Name

4-[1-methyl-3-(pyrrolidine-1-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-4-oxo-N-[(thiophen-2-yl)methyl]butanamide

IUPAC name

4-[1-methyl-3-(pyrrolidine-1-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]-4-oxo-N-[(thiophen-2-yl)methyl]butanamide

SMILES

Cn1nc(C(N2CCCC2)=O)c(C2)c1CCN2C(CCC(NCc1cccs1)=O)=O

InChI

InChI=1S/C21H27N5O3S/c1-24-17-8-11-26(14-16(17)20(23-24)21(29)25-9-2-3-10-25)19(28)7-6-18(27)22-13-15-5-4-12-30-15/h4-5,12H,2-3,6-11,13-14H2,1H3,(H,22,27)

InChI Key

OBRSVMKAPZAENG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27463489

C21H27N5O3S (L575-0190) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C21H27N5O3S (L575-0190) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C21H27N5O3S (L575-0190)?
Check Price and Availability of C21H27N5O3S (L575-0190), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C21H27N5O3S (L575-0190) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C21H27N5O3S (L575-0190)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C21H27N5O3S (L575-0190)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C21H27N5O3S (L575-0190) available by request